New and traditional serum markers of bone metabolism in the detection of skeletal metastases

Clinical Biochemistry

Volumn 29, Issue 1, 1996, Pages 67-72

  Plebani, M ^a   Bernardi, D ^c   Zaninotto, M ^b   De Paoli, M ^c   Secchiero, S ^a   Sciacovelli, L ^a  

^a Center for Biomedical Research   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c NONE

Author keywords

alkaline phosphatase; bone isoenzyme; carboxyterminal propeptide of type I procollagen; carboxyterminal telopeptide of type I collagen; osteocalcin; skeletal metastases; tartrate resistant acid phosphatase

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; COLLAGEN TYPE 1; ISOENZYME; OSTEOCALCIN; PROCOLLAGEN; TARTARIC ACID;

ADULT; AGED; ARTICLE; BONE METABOLISM; BONE METASTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; IMMUNORADIOMETRIC ASSAY; PRIORITY JOURNAL; RADIOIMMUNOASSAY;

EID: 0030034427     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-9120(95)02001-2     Document Type: Article

References (25)

1. Kagan AR, Gilbert HA, The detection of occult metastases with imaging studies. Int J Radiat Oncol Biol Phys 1976; 1: 529-33.
2. Galasko CSB. The value of scintigraphy in malignant disease. Cancer Treat Rev 1975; 2: 225-72.
3. O'Mara RE. Skeletal scanning in neoplastic disease. Cancer 1976; 37: 480-6.
4. Masters PW, Jones RG, Purves DA, Cooper EH, Cooney JM. Commercial assays for serum osteocalcin give clinically discordant results. Clin Chem 1994; 40(3): 358-63.
5. Delmas PD, Christiansen C, Mann KG, Price PA. Bone Gla protein (osteocalcin) assay standardization report. J Bone Miner Res 1990; 5: 5-11.
6. Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982; 34: 285-90.
7. Susi FR, Goldhaber P, Jennings JM. Histochemical and biochemical study of acid phosphatase in resorbing bone in culture. Am J Physiol 1966; 211: 959-62.
8. Scarnecchia L, Minisola S, Pacitti MT, Carnevale V, Romagnoli E, Rosso R et al. Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnover. Scand J Clin Lab Invest 1991; 51: 517-24.
9. William Law KH, Onishi T, Wergedal JE, Singer FR, Baylink DJ. Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin Chem 1987; 33(4): 458-62.
10. Moss DW. Changes in enzyme expression related to differentiation and regulatory factors: the acid phosphatase of osteoclast and other macrophages. Clin Chim Acta 1992; 209: 131-8.
11. Burlina A, Rubin D, Secchiero S, Sciacovelli L, Zaninotto M, Plebani M. Monitoring skeletal cancer metastases with the bone isoenzyme of tissue unspecific alkaline phosphatase. Clin Chim Acta 1994; 226: 151-8.
12. Van Hoof VO, Van Oosterom AT, Lepoutre LG, De Broe ME. Alkaline phosphatase isoenzyme patterns in malignant disease. Clin Chem 1992; 38(12): 2546-51.
13. Mayne PD, Thakrar S, Rosalki SB, Foo AY, Parbhoo S. Identification of bone and liver metastases from breast cancer by measurement of plasma alkaline phosphatase isoenzyme activity. J Clin Pathol 1987; 40: 398-403.
14. Delmas PD. Biochemical markers of bone turnover: methodology and clinical use in osteoporosis. Am J Med 1991; 91(Suppl 5B): 59-63.
15. Melkko J, Niemi S, Risteli L, Risteli J. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen. Clin Chem 1990; 36(7): 1328-32.
16. Eriksen EF, Charles P, Melsen F, Mosekilde L, Risteli L, Risteli J. Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation to bone histomorphometry. J Bone Miner Res 1993; 8(2): 127-32.
17. Eriksen EF, Charles P, Mosekilde L, Risteli L, Risteli J. Cross-linked carboxyterminal telopeptide of type I collagen in serum (S-ICTP): A new bone resorption marker. J Bone Miner Res 1991; 6(suppl): 637.
18. Rosalki SB, Foo AY. Two new methods for separating and quantifying bone and liver alkaline phosphatase isoenzymes in plasma. Clin Chem 1984; 30: 1182-6.
19. Gerhardt W, Olsson V. A computer programme for graphical evaluation of test data from clinical studies. Progr Med Lab 1990; 4: 111-5.
20. Gerhardt W, Keller H. Evaluation of test data from clinical studies. I. Terminology, graphic interpretations, diagnostic strategies and selection of sample groups. II. Critical review of the concepts of efficiency, receiver operating characteristic (ROC) and likelihood ratios. Scand J Clin Lab Invest 1986; 181(Suppl): 11-74.
21. Hanley JA, McNeil BJ. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 1982; 143: 29-36.
22. Hanley JA, McNeil BJ. A method of comparing the area under receiver operating characteristic curves derived from the same cases. Radiology 1983; 148: 839-943.
23. Deftos LJ, Glowacki J. Mechanisms of bone metabolism. (Review). In: Kem DC, Frohlich E, Eds. Pathophysiology. 3rd ed. Pp. 445-68. Philadelphia: JB Lippincott Co, 1984.
24. Walton RJ, Preston CJ, Russell RGG, Kanis JA. An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease. Clin Chim Acta 1975; 63: 227-9.
25. Slovik DM, Gundberg CM, Neer RM, Lian JB. Clinical evaluation of bone turnover by serum osteocalcin measurements in a hospital setting. J Clin Endocrinol Metab 1984; 59: 228-30.